United States - English - NLM (National Library of Medicine)

butler animal health - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 10 mg in 1 ml - indications: k-ject injection is indicated in coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. k-ject injection is indicated in cattle, calves, horses, swine, sheep, goats, dogs, and cats to counter hypoprothrombinemia induced by ingestion of anticoagulant rodenticides. k-ject injection is also indicated to counter hypoprothrombinemia caused by consumption of bishydroxycoumarin found in a spoiled and moldy sweet clover. contraindications: hypersensitivity to any component of this medication.

United States - English - NLM (National Library of Medicine)

rebel distributors corp - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg - mephyton is indicated in the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton tablets are indicated in: - anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives; - hypoprothrombinemia secondary to antibacterial therapy; - hypoprothrombinemia secondary to administration of salicylates; - hypoprothrombinemia secondary to obstructive jaundice or biliary fistulas but only if bile salts are administered concurrently, since otherwise the oral vitamin k will not be absorbed. hypersensitivity to any component of this medication.

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 5 mg

United States - English - NLM (National Library of Medicine)

neogen corporation - nandino - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - phytonadione 10 mg in 1 ml - ​for animal use only

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - vitamin k1 injection (phytonadione injectable emulsion, usp) is indicated in the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. vitamin k1 injection is indicated in: anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives; prophylaxis and therapy of hemorrhagic disease of the newborn; hypoprothrombinemia due to antibacterial therapy; hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin k, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin k metabolism, e.g., salicylates. hypersensitivity to any component of this medication.

United States - English - NLM (National Library of Medicine)

a-s medication solutions - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - vitamin k1 injection (phytonadione injectable emulsion, usp) is indicated in the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. vitamin k1 injection is indicated in: - anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives; anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives; - prophylaxis and therapy of hemorrhagic disease of the newborn; prophylaxis and therapy of hemorrhagic disease of the newborn; - hypoprothrombinemia due to antibacterial therapy; hypoprothrombinemia due to antibacterial therapy; - hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin k, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; hypoprothrombinemia secondary to factors limiting

United States - English - NLM (National Library of Medicine)

a-s medication solutions - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - vitamin k1 injection (phytonadione injectable emulsion, usp) is indicated in the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. vitamin k1 injection is indicated in: - anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives; anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives; - prophylaxis and therapy of hemorrhagic disease of the newborn; prophylaxis and therapy of hemorrhagic disease of the newborn; - hypoprothrombinemia due to antibacterial therapy; hypoprothrombinemia due to antibacterial therapy; - hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin k, e.g., obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis; hypoprothrombinemia secondary to factors limiting

United States - English - NLM (National Library of Medicine)

a-s medication solutions - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) - mephyton is indicated in the following coagulation disorders which are due to faulty formation of factors ii, vii, ix and x when caused by vitamin k deficiency or interference with vitamin k activity. mephyton tablets are indicated in: hypersensitivity to any component of this medication.

United States - English - NLM (National Library of Medicine)

truemed group llc - phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) -

United States - English - NLM (National Library of Medicine)

crown general agency inc - cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate (unii: 9e8x80d2l0) (.alpha.-tocopherol - unii:h4n855pnz1), phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), biotin (uni - take two (2) capsules two times a day, after meal(s), or as directed by your healthcare provider. do not exceed four (4) capsules daily.